|
|
Article: Nitric oxide improves drug efficacy.(NicOx S.A.)(Brief Article)
- Article from:
- Chemistry and Industry
- Article date:
- January 22, 2001
CopyrightCOPYRIGHT 2001 Society of Chemical Industry. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
'NicOx has in development what is potentially a multi-billion-dollar drug. Even if that drug fails, NicOx's product pipeline is one of the most promising in the biotechnology industry at the present time.'
This is one city analyst's summary of the French biopharmaceutical company, following a recent NicOx technology presentation. The company was established in 1996 with the aim of commercially exploiting the action of nitric oxide (NO). NO is a gas that is produced throughout the body. First identified in the 1970s, it has stimulated a great deal of scientific research into its wide-ranging effects.
The multi-billion-dollar drug in question is NCX 3012, ...